A Study to Assess the Effect of Single Doses of Daridorexant on Electrocardiogram Parameters in Healthy Subjects

NCT04250506 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Daridorexant
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Idorsia Pharmaceuticals Ltd.